Regulus Therapeutics reported $26.6M in Market Capitalization this February of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Astrazeneca AZN:US USD 171.96B 31.78B
AstraZeneca AZN:LN USD 154.08B 13.26B
Biogen BIIB:US USD 39.1B 9.24B
Celldex Therapeutics CLDX:US USD 1.32B 53M
Gilead Sciences GILD:US USD 107.68B 30.32B
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Intrexon XON:US USD 441M 163M
Lexicon Pharmaceuticals LXRX:US USD 441M 163M
Ligand Pharmaceuticals LGND:US USD 1.45B 50M
Merk MRK:US USD 281.3B 63.14B
Omeros OMER:US USD 198M 25M
Regulus Therapeutics RGLS:US USD 25M 5M
Sangamo Biosciences SGMO:US USD 767M 160M
Sanofi SNY:US EUR 121.87B 24.49B
Spectrum Pharmaceuticals SPPI:US USD 87M 57M
Takeda 4502:JP JPY 6.41T 451.4B
Vital Therapies VTL:US USD 97M 21M
YTE INCY:US USD 14.82B 2.01B